{"corpus_id":28210119,"paper_sha":"22b9192a1b33122e56f19cb463f0f4abf6c4d4ba","doi":"10.1111/ajt.13583","arxiv_id":null,"pmid":26731039,"pmcid":null,"mag_id":2225598974,"dblp_id":null,"acl_id":null,"title":"Long‐Term Outcomes of Living‐Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study","year":2016,"publication_date":"2016-04-01","venue":"American Journal of Transplantation","journal":{"name":"American Journal of Transplantation","pages":"1248 - 1257","volume":"16"},"journal_issn":null,"journal_title":null,"publication_types":["Study","JournalArticle"],"pubmed_pub_types":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Medicine"],"reference_count":38,"citation_count":44,"influential_citation_count":3,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adolescent","mj":false,"ui":"D000293"},{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Follow-Up Studies","mj":false,"ui":"D005500"},{"d":"Graft Rejection","mj":false,"qs":[{"q":"etiology","mj":false,"ui":"Q000209"},{"q":"prevention & control","mj":true,"ui":"Q000517"}],"ui":"D006084"},{"d":"Graft Survival","mj":false,"ui":"D006085"},{"d":"HLA Antigens","mj":false,"qs":[{"q":"immunology","mj":true,"ui":"Q000276"}],"ui":"D006680"},{"d":"Histocompatibility Testing","mj":false,"ui":"D006650"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Immunosuppressive Agents","mj":false,"qs":[{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D007166"},{"d":"Japan","mj":false,"ui":"D007564"},{"d":"Liver Cirrhosis, Biliary","mj":false,"qs":[{"q":"surgery","mj":true,"ui":"Q000601"}],"ui":"D008105"},{"d":"Liver Transplantation","mj":true,"ui":"D016031"},{"d":"Living Donors","mj":true,"ui":"D019520"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Postoperative Complications","mj":false,"ui":"D011183"},{"d":"Prognosis","mj":false,"ui":"D011379"},{"d":"Retrospective Studies","mj":false,"ui":"D012189"},{"d":"Risk Factors","mj":false,"ui":"D012307"},{"d":"Survival Rate","mj":false,"ui":"D015996"},{"d":"Time Factors","mj":false,"ui":"D013997"},{"d":"Young Adult","mj":false,"ui":"D055815"}],"chemicals":[{"n":"HLA Antigens","ui":"D006680","reg":"0"},{"n":"Immunosuppressive Agents","ui":"D007166","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.13583","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/22b9192a1b33122e56f19cb463f0f4abf6c4d4ba","s2_open_access_license":"CCBYNCND","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The factors that influence long‐term outcomes after living‐donor liver transplantation (LDLT) for primary biliary cirrhosis (PBC) are not well known. Compared with deceased‐donor transplantation, LDLT has an increased likelihood of a related donor and a decreased number of human leukocyte antigen (HLA) mismatches. To clarify the effects of donor relatedness and HLA mismatch on the outcomes after LDLT, we retrospectively analyzed 444 Japanese patients. Donors were blood relatives for 332 patients, spouses for 105, and “other” for 7. The number of HLA A‐B‐DR mismatches was none to two in 141, three in 123, and four to six in 106 patients. The 15‐year survival rate was 52.6%, and PBC recurred in 65 patients. Recipient aged 61 years or older, HLA mismatches of four or more (maximum of six), graft:recipient weight ratio less than 0.8, and husband donor were adverse indicators of patient survival. IgM 554 mg/dL or greater, donor–recipient sex mismatch, and initial immunosuppression with cyclosporine were significant risks for PBC recurrence, which did not affect patient survival. In subgroup analysis, conversion to cyclosporine from tacrolimus within 1 year diminished recurrence. Prospective studies are needed to determine the influence of pregnancy‐associated sensitization and to establish an optimal immunosuppressive regimen in LDLT patients.","claims":[{"public_id":"cl_bc9ac3b474528dbf0029cbcbb515c42f","status":"active","text":"A retrospective analysis included 444 Japanese patients who underwent living-donor liver transplantation for primary biliary cirrhosis.","confidence":0.98,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_bc9ac3b474528dbf0029cbcbb515c42f"},{"public_id":"cl_dd10020520734cbe7eaeb5ae495b8694","status":"active","text":"Conversion to cyclosporine from tacrolimus within 1 year diminished PBC recurrence in subgroup analysis.","confidence":0.9,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_dd10020520734cbe7eaeb5ae495b8694"},{"public_id":"cl_6568d0f4b6f3ef3014f97a1887be78da","status":"active","text":"IgM 554 mg/dL or greater, donor-recipient sex mismatch, and initial immunosuppression with cyclosporine were significant risks for PBC recurrence, which did not affect patient survival.","confidence":0.95,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_6568d0f4b6f3ef3014f97a1887be78da"},{"public_id":"cl_cda998564d58ccfcac2fc9049d0f1972","status":"active","text":"Recipient aged 61 years or older, HLA mismatches of four or more, graft:recipient weight ratio less than 0.8, and husband donor were adverse indicators of patient survival.","confidence":0.96,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_cda998564d58ccfcac2fc9049d0f1972"},{"public_id":"cl_916c1f18c779c9ffd9a154d15a1e0c45","status":"active","text":"The 15-year survival rate after living-donor liver transplantation for primary biliary cirrhosis was 52.6%, and primary biliary cirrhosis recurred in 65 patients.","confidence":0.97,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_916c1f18c779c9ffd9a154d15a1e0c45"}],"concepts":[{"public_id":"co_024965e87b064b84039c9142ae0e3d10","status":"active","name":"conversion to cyclosporine from tacrolimus","description":"A change in immunosuppressive therapy from tacrolimus to cyclosporine within 1 year.","types":["treatment change"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_024965e87b064b84039c9142ae0e3d10"},{"public_id":"co_26117147d301158fd447fd7357da914b","status":"active","name":"donor-recipient sex mismatch","description":"A donor and recipient pairing in which the donor and recipient are of different sexes.","types":["risk factor"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_26117147d301158fd447fd7357da914b"},{"public_id":"co_4e2f9c06b7edab9030a4f92bd5e7a8c5","status":"active","name":"living-donor liver transplantation","description":"A liver transplant procedure using a living donor, examined here as treatment for primary biliary cirrhosis.","types":["procedure"],"aliases":["LDLT"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4e2f9c06b7edab9030a4f92bd5e7a8c5"},{"public_id":"co_545cc14968caaabc10228873e575b45b","status":"active","name":"primary biliary cirrhosis","description":"The liver disease for which the Japanese patients received living-donor liver transplantation.","types":["condition"],"aliases":["PBC"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_545cc14968caaabc10228873e575b45b"},{"public_id":"co_54eca3690cf76b5bae2d37d1360889fa","status":"active","name":"patient survival","description":"The survival outcome of recipients after living-donor liver transplantation.","types":["outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_54eca3690cf76b5bae2d37d1360889fa"},{"public_id":"co_6f212094df697368f23407f92bb2c9c0","status":"active","name":"graft:recipient weight ratio","description":"A measure comparing transplanted graft weight with recipient body weight.","types":["clinical measure"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6f212094df697368f23407f92bb2c9c0"},{"public_id":"co_76e14642dbe56218ad51d0a848e7fbda","status":"active","name":"15-year survival rate","description":"The long-term patient survival endpoint reported 15 years after transplantation.","types":["outcome measure"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_76e14642dbe56218ad51d0a848e7fbda"},{"public_id":"co_7c3ac4707a66d4aecc15c7c43657b666","status":"active","name":"Japanese patients","description":"The patient population retrospectively analyzed after living-donor liver transplantation.","types":["population"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7c3ac4707a66d4aecc15c7c43657b666"},{"public_id":"co_875c04faa4758e70e1e3e21db25dde3a","status":"active","name":"IgM","description":"An immunoglobulin measure evaluated as a risk factor for recurrence after transplantation.","types":["biomarker"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_875c04faa4758e70e1e3e21db25dde3a"},{"public_id":"co_8d54d9dd733b4061885887091d7ce0a8","status":"active","name":"PBC recurrence","description":"Return of primary biliary cirrhosis after living-donor liver transplantation.","types":["outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8d54d9dd733b4061885887091d7ce0a8"},{"public_id":"co_a055ef46ca48b1646d5dabb2f87b4b09","status":"active","name":"initial immunosuppression with cyclosporine","description":"Use of cyclosporine as the initial immunosuppressive regimen after transplantation.","types":["treatment regimen"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a055ef46ca48b1646d5dabb2f87b4b09"},{"public_id":"co_c6ffb23874974c746875260807a00ccb","status":"active","name":"donor relatedness","description":"The relationship category between liver donors and recipients, including blood relatives, spouses, and other donors.","types":["variable"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c6ffb23874974c746875260807a00ccb"},{"public_id":"co_c82ae6d566f093df861262e595dcf46d","status":"active","name":"subgroup analysis","description":"A secondary analysis performed on a subset of patients in the transplantation cohort.","types":["analysis method"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c82ae6d566f093df861262e595dcf46d"},{"public_id":"co_e066a124ce3e2652a4d30b57dd26232b","status":"active","name":"HLA A-B-DR mismatches","description":"The counted human leukocyte antigen mismatches at A, B, and DR loci between donor and recipient.","types":["immunologic measure"],"aliases":["human leukocyte antigen A-B-DR mismatches"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e066a124ce3e2652a4d30b57dd26232b"}],"external_ids":{"DOI":"10.1111/ajt.13583","ArXiv":null,"PubMed":26731039,"PubMedCentral":null,"MAG":2225598974,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.13583","landing_url":"https://www.semanticscholar.org/paper/22b9192a1b33122e56f19cb463f0f4abf6c4d4ba","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNCND","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":630838,"paper_uid":"8c76b635-977e-442e-bc45-3c4c3f57f3ca","canonical_identity":{"paper_id":630838,"paper_uid":"8c76b635-977e-442e-bc45-3c4c3f57f3ca","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/28210119"}